The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
INTENSIVE: InterNaTional rEgistry oN Sars-cov-2 posItiVe nEuroendocrine neoplasm patients.
 
Francesca Spada
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Novartis
Speakers' Bureau - Advanced Accelerator Applications; Ipsen; Novartis
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Ipsen; Novartis
 
Lorenzo Gervaso
No Relationships to Disclose
 
Anna La Salvia
No Relationships to Disclose
 
Rocio Garcia-Carbonero
Honoraria - Advanced Accelerator Applications; Advanz Pharma; AstraZeneca (I); Bayer; Boehringer Ingelheim (I); Bristol-Myers Squibb (I); Gilead Sciences (I); HMP; Ipsen; Lilly (I); MERCK; Merck (I); Midatech Pharma; MSD; NOVARTIS; PFIZER; PharmaMar; PharmaMar (I); Pierre Fabre; ROCHE; Roche (I); Sanofi; SERVIER; SERVIER (I); Sysmex (I)
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; HMP; Ipsen; Merck; MSD; Novartis; Pfizer; PharmaMar; Pierre Fabre
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Merck; Roche
 
Jorge Hernando
Speakers' Bureau - Advanced Accelerator Applications; Angelini Pharma; Eisai; Ipsen; Roche
Travel, Accommodations, Expenses - Advanced Accelerator Applications; AstraZeneca; Eisai; Ipsen; Novartis; Roche
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Exelixis; Ipsen; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Speakers' Bureau - Bayer; Eisai; Ipsen; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Ipsen (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Eisai; Ipsen; Pfizer
 
Johannes Hofland
Consulting or Advisory Role - Ipsen
Speakers' Bureau - Ipsen; Novartis
 
Wouter de Herder
No Relationships to Disclose
 
Anna Koumarianou
Honoraria - Merck; Pfizer
Consulting or Advisory Role - Ipsen; Novartis
Travel, Accommodations, Expenses - Genesis Pharma; Roche
 
Maura Rossi
No Relationships to Disclose
 
Sabrina Boselli
No Relationships to Disclose
 
Darina Tamayo
No Relationships to Disclose
 
Vincenzo Bagnardi
No Relationships to Disclose
 
Alice Laffi
No Relationships to Disclose
 
Manila Rubino
No Relationships to Disclose
 
Mohamad Bassam Sonbol
No Relationships to Disclose
 
Nicola Fazio
Honoraria - Advanced Accelerator Applications; Ipsen; Merck; Novartis; Sanofi
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Merck Serono; MSD Oncology; Novartis/Ipsen; Pfizer
Research Funding - Ipsen (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst)
Other Relationship - Il Pensiero Scientifico Editore; Springer
 
Thorvardur Ragnar Halfdanarson
Consulting or Advisory Role - Advanced Accelerator Applications (Inst); Curium Pharma; Ipsen (Inst); Lexicon (Inst); ScioScientific; TERUMO
Research Funding - Advanced Accelerator Applications (Inst); Agios (Inst); Basilea (Inst); Ipsen (Inst); Novartis (Inst); Thermo Fisher Scientific (Inst); Turnstone Bio (Inst)